Project XPF-008-201

Basic data

Title:
XPF-008-201
Duration:
14/03/2020 to 14/03/2023
Abstract / short description:
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability and efficacy of XEN1101 as adjunctive therapy in focal-onset epilepsy, with an open-label extension

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Other staff

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology, Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Burnaby, British Columbia, Canada
Help

will be deleted permanently. This cannot be undone.